JB Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapies for orphan inflammatory diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Newton Center
State: Massachusetts
Zip:
Country: United States
JB Therapeutics is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Their lead compound, JBT-101, is a potent CB1 and CB2 agonist with demonstrated efficacy in several animal models of pain and inflammation. It has also completed a Phase II clinical study in chronic refractory neuropathic pain. JBT-101 is currently being developed as a potential disease modifying treatment for osteoarthritis. JBT-101 also represents a platform for combination with other anti-inflammatory and analgesic agents as well as various drug delivery strategies including ointment and gels, topical patches, and timed release formulations.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2012 | Venture Round | 1 | $662k |
Maine Angels Maine Angels |
1/2014 | Seed Round | 1 | $25k |
Maine Angels Maine Angels |
6/2009 | Angel Round | 1 | - |
Boston Harbor Angels Boston Harbor Angels |
6/2009 | Angel Round | 1 | - |
Boston Harbor Angels Boston Harbor Angels |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|